Accelerate Diagnostics Inc
NASDAQ:AXDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Accelerate Diagnostics Inc
NASDAQ:AXDX
|
US |
|
L
|
LunR Royalties Corp
XTSX:LUNR
|
CA |
|
Leatt Corp
OTC:LEAT
|
ZA |
|
SMS Alternatives Inc
OTC:CICN
|
US |
|
O
|
Odlewnie Polskie SA
WSE:ODL
|
PL |
|
Dillistone Group PLC
LSE:DSG
|
UK |
|
P
|
PT UBC Medical Indonesia Tbk
IDX:LABS
|
ID |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AXDX's stock price target?
Not Available
AXDX doesn't have any price targets made by Wall Street professionals.
What is Accelerate Diagnostics Inc's Revenue forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Accelerate Diagnostics Inc's revenue is
20%.
The projected
CAGR
for the next 1 year is
7%.